Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

AdvisorShares Pure US Cannabis ETF MSOS

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified.


ARCA:MSOS - Post by User

Post by Bullknit101on May 17, 2022 4:11pm
53 Views
Post# 34690299

THCV the next CBD

THCV the next CBD https://thedalesreport.com/interviews/inmed-pharmaceuticals-commercializing-the-development-of-rare-cannabinoids-for-the-wellness-market/
<< Previous
Bullboard Posts
Next >>